It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Compare tax exposure between dividend ETFs and taxable funds in 2024 to identify the lower-tax option for your goals.
28,172 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Costco posted solid June numbers, with a 10.6% rise in sales and a strong e-commerce lift. Yet the stock declined, si...
When markets wobble, investors ask a familiar question: should sell your stocks? History shows a simple rule: avoid p...
As tax policy and market conditions evolve, a single variable—current versus retirement tax rate—drives whether tradi...
O-I Glass has climbed about 17% over the past year, even as a large fund unloaded roughly $80 million worth of stock....
Apple and Nvidia sit at the pinnacle of market caps, but they play very different roles in investors’ portfolios. Thi...
IBM rallied today on a blend of solid earnings, growing cloud demand, and quantum computing momentum backed by govern...
Ownwell secures a $50M Series B to broaden its AI-driven tax-appeals platform and roll out a nationwide packet for ho...
Anna Duggar’s Instagram comeback signals more than a public return. This in-depth piece breaks down what it means for...
A mom of four faced big financial odds when her spouse traveled for work. This story explains how she built a 4-renta...
Five ETFs are being pitched as the cleanest way to play embodied AI, a thesis many traders say aligns with Jensen Hua...
The SPDR S&P Semiconductor ETF jumps roughly 12% amid resilient AI-related demand, yet Intel remains a weakness in an...